ACET Adicet Bio Inc

Price (delayed)

$9.11

Market cap

$85.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$13.87

Enterprise value

$59.95M

?
Relative Growth: Rel. Growth: 17
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” ...

Highlights
ACET's EPS is up by 33% year-on-year and by 18% since the previous quarter
Adicet Bio's debt has decreased by 14% YoY and by 6% QoQ
The quick ratio has decreased by 18% YoY but it has increased by 2.4% from the previous quarter
Adicet Bio's equity has decreased by 13% YoY and by 12% QoQ

Key stats

What are the main financial stats of ACET

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
0.55%
1 week
16.94%
1 month
5.44%
1 year
-16.96%
YTD
8.19%
QTD
5.44%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$113.8M
Net income
-$108.83M
Gross margin
N/A
Net margin
N/A
ACET's operating income is up by 10% YoY and by 7% from the previous quarter
The company's net income rose by 7% YoY and by 7% QoQ

Price vs fundamentals

How does ACET's price correlate with its fundamentals

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.62
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS is up by 33% year-on-year and by 18% since the previous quarter
ACET's price to book (P/B) is 31% lower than its 5-year quarterly average of 0.9 but 24% higher than its last 4 quarters average of 0.5
Adicet Bio's equity has decreased by 13% YoY and by 12% QoQ

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE is down by 36% YoY but it is up by 3.1% QoQ
Adicet Bio's return on assets has decreased by 29% YoY but it has increased by 3.8% QoQ
Adicet Bio's ROIC has increased by 6% YoY

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
ACET's current ratio is down by 18% year-on-year but it is up by 2.4% since the previous quarter
The quick ratio has decreased by 18% YoY but it has increased by 2.4% from the previous quarter
Adicet Bio's debt is 90% lower than its equity
Adicet Bio's debt has decreased by 14% YoY and by 6% QoQ
Adicet Bio's equity has decreased by 13% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.